$CMGO
CMG HOLDINGS GROUP, INC. Stock $cmgo

$cmgo Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000101738623000162 Filed on April 17, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$159.6K	$147.0K	$2.034M
YoY Change	-60.87%	-73.83%	25.63%
Cost Of Revenue	$129.5K	$122.9K	$1.502M
YoY Change	-55.34%	-75.26%	23.7%
Gross Profit	$30.12K	$24.04K	$531.7K
YoY Change	-74.47%	-62.9%	31.41%
Gross Profit Margin	18.87%	16.36%	26.14%
Selling, General & Admin	$150.0K	$175.8K	$683.2K
YoY Change	1.34%	-4.73%	-3.51%
% of Gross Profit	497.99%	731.24%	128.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$620.00	$920.00	$3.714K
YoY Change	-33.33%	0.0%	0.11%
% of Gross Profit	2.06%	3.83%	0.7%
Operating Expenses	$150.0K	$175.8K	$683.2K
YoY Change	1.35%	-4.73%	-3.51%
Operating Profit	-$119.9K	-$151.8K	-$151.5K
YoY Change	299.5%	26.76%	-50.06%
Interest Expense	$9.750K	$26.81K	$106.6K
YoY Change	32.29%
% of Operating Profit
Other Income/Expense, Net	$22.68K		$169.1K
YoY Change	207.71%		-84.52%
Pretax Income	-$119.9K	-$124.9K	-$164.7K
YoY Change	429.56%	46.69%	-120.86%
Income Tax
% Of Pretax Income
Net Earnings	-$97.22K	-$124.9K	$17.62K
YoY Change	329.4%	46.69%	-97.77%
Net Earnings / Revenue	-60.91%	-85.02%	0.87%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	438.7M shares	438.7M shares	438.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$227.4K	$338.2K	$338.2K
YoY Change	-56.09%	-43.21%	-43.21%
Cash & Equivalents	$227.4K	$338.2K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.890M	$1.953M	$1.953M
YoY Change	7.5%	9.34%	9.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.862K	$2.483K	$2.480K
YoY Change	-64.67%	-59.93%	-60.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.862K	$2.483K	$2.480K
YoY Change	-64.67%	-59.93%	-60.0%
TOTAL ASSETS
Total Short-Term Assets	$1.890M	$1.953M	$1.953M
Total Long-Term Assets	$1.862K	$2.483K	$2.480K
Total Assets	$1.891M	$1.955M	$1.955M
YoY Change	7.28%	9.1%	9.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.76K	$39.01K	$39.01K
YoY Change
Accrued Expenses		$39.01K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$797.0K	$797.0K	$797.0K
YoY Change	38.61%	38.61%	38.61%
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$1.255M	$1.222M	$1.222M
YoY Change	17.33%	13.52%	13.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.255M	$1.222M	$1.222M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.255M	$1.222M	$1.222M
YoY Change	17.33%	13.52%	13.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.43M	-$14.34M
YoY Change		-0.12%
Common Stock	$438.7K	$438.7K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$636.7K	$733.9K	$733.9K
YoY Change
Total Liabilities & Shareholders Equity	$1.891M	$1.955M	$1.955M
YoY Change	7.28%	9.1%	9.1%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$97.22K	-$124.9K	$17.62K
YoY Change	329.4%	46.69%	-97.77%
Depreciation, Depletion And Amortization	$620.00	$920.00	$3.714K
YoY Change	-33.33%	0.0%	0.11%
Cash From Operating Activities	-$95.77K	-$164.0K	-$178.8K
YoY Change	69.26%	-138.42%	-126.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$258.5K	-$300.4K
YoY Change	-100.0%	-932.26%
Cash From Investing Activities		-$258.5K	-$300.4K
YoY Change		-932.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$15.00K	222.0K	$222.0K
YoY Change		-144.22%	-144.66%
NET CHANGE
Cash From Operating Activities	-95.77K	-164.0K	-178.8K
Cash From Investing Activities		-258.5K	-$300.4K
Cash From Financing Activities	-$15.00K	222.0K	$222.0K
Net Change In Cash	-$110.8K	-200.5K	-$257.3K
YoY Change		352.94%
FREE CASH FLOW
Cash From Operating Activities	-$95.77K	-$164.0K	-$178.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001346655
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties		usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q4	cmgo	Paycheck Protection Loan PaycheckProtectionLoan		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2022	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee		usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans		usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-51770
CY2022	dei	Entity Registrant Name EntityRegistrantName	CMG HOLDINGS GROUP, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0733770
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2130 North Lincoln Park West 8N
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60614
CY2022	dei	City Area Code CityAreaCode	(773)
CY2022	dei	Local Phone Number LocalPhoneNumber	770-3440
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	1623086	usd
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	438672016	shares
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	338156	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	595430	usd
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	100000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1514764	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1190648	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1952920	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1786078	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2483	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6197	usd
CY2022Q4	us-gaap	Assets Assets	1955403	usd
CY2021Q4	us-gaap	Assets Assets	1792275	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	39014	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	385514	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	438514	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	722000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	500000	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	15000	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	15000	usd
CY2021Q4	cmgo	Paycheck Protection Loan PaycheckProtectionLoan	62500	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	60000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	60000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1221525	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1076014	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1221525	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1076014	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	438672016	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	438672016	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	438672016	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	438672016	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	438672	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	438672	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14630689	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14630689	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14335483	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14353100	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	733878	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	716261	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1955403	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1792275	usd
CY2022	us-gaap	Revenues Revenues	2033712	usd
CY2021	us-gaap	Revenues Revenues	1618874	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1502046	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1214281	usd
CY2022	us-gaap	Gross Profit GrossProfit	531666	usd
CY2021	us-gaap	Gross Profit GrossProfit	404593	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	683187	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	708007	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	683187	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	708007	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-151521	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-303414	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	123677	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	35507	usd
CY2022	cmgo	Interest Expense1 InterestExpense1	-17039	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-48750	usd
CY2021	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	589115	usd
CY2022	cmgo	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	62500	usd
CY2021	cmgo	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	45792	usd
CY2021	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	471120	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	169138	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1092784	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	17617	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	789370	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	438672016	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	438672016	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0020
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-73109	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	789370	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	716261	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	17617	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	733878	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	17617	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	789370	usd
CY2022	us-gaap	Depreciation Depreciation	3714	usd
CY2021	us-gaap	Depreciation Depreciation	3714	usd
CY2022	cmgo	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	62500	usd
CY2021	cmgo	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	45792	usd
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-123677	usd
CY2021	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-35507	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	39012	usd
CY2022	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-53000	usd
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-44862	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	24941	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10500	usd
CY2022	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-178834	usd
CY2021	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	681364	usd
CY2022	us-gaap	Proceeds From Loans ProceedsFromLoans	222000	usd
CY2021	us-gaap	Proceeds From Loans ProceedsFromLoans	562500	usd
CY2021	us-gaap	Payments For Loans PaymentsForLoans	68750	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	222000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-493750	usd
CY2022	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	100000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	200440	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	990820	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-300440	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-990820	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-257274	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	184294	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	595430	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411136	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	338156	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	595430	usd
CY2019Q4	us-gaap	Loans Receivable Basis Spread On Variable Rate LoansReceivableBasisSpreadOnVariableRate	0.12	pure
CY2020	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	32500	usd
CY2020	cmgo	Convert Loan Receivable To Shares ConvertLoanReceivableToShares	100	shares
CY2020	cmgo	Convert Loan Receivable To Amount ConvertLoanReceivableToAmount	1000	usd
CY2020Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	50000	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	999201	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	60000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zWBdr0FUxRr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><b>1 Nature of Operations and Continuance of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify">Creative Management Group, Inc. was formed in Delaware on August 13, 2002 as a limited liability company named Creative Management Group, LLC. On August 7, 2007, this entity converted to a corporation. The Company is a sports, entertainment, marketing and management company providing event management implementation, sponsorships, licensing and broadcast, production and syndication.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 38.95pt 0 60pt; text-align: justify">The Company’s operating subsidiaries are XA - The Experiential Agency, Inc. - which is a sports, entertainment, marketing and management company providing event management implementation, sponsorships, licensing and broadcast, production and syndication. Its President is Alexis Laken, the daughter of the Company’s president. The other subsidiary is Lincoln Acquisition Corp. which was formed for the purpose of liquidating shares in Good Gaming, Inc. and any other investment shares which might be held by CMG at any given time.</p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zV8ZXAQcyG9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-indent: 20pt">b) Use of Estimates<i> </i></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.05pt 0 0"> </p> <p style="font: 9.5pt/106% Times New Roman, Times, Serif; margin: 0 8.7pt 0 42.75pt; text-align: justify">The preparation of financial statements in conformity with <span style="letter-spacing: -0.15pt">generally </span>accepted accounting principles in the <span style="letter-spacing: 0.1pt">United </span>States requires management to make estimates and assumptions that affect the reported amounts of assets and li abilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions <span style="letter-spacing: 0.1pt">related </span>to the recoverability of its long-lived assets, stock-based <span style="letter-spacing: -0.05pt">compensation</span>, <span style="letter-spacing: -0.05pt">an</span>d def<span style="letter-spacing: -0.7pt">er</span>red <span style="letter-spacing: -0.05pt">incom</span>e tax asset valuation allownaces. <span style="letter-spacing: -0.05pt">Th</span>e <span style="letter-spacing: -0.05pt">Compan</span>y bases <span style="letter-spacing: -0.05pt">it</span>s <span style="letter-spacing: -0.05pt">estimate</span>s <span style="letter-spacing: -0.05pt">and </span>assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company's estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.25pt 0 0"> </p>
CY2020	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
	us-gaap	Debt Instrument Maturity Date Range End1 DebtInstrumentMaturityDateRangeEnd1	2023-12-24
CY2022	us-gaap	Reclassifications Reclassifications	<p id="xdx_84B_eus-gaap--Reclassifications_zjU52pOjw2M6" style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-indent: 20pt">h) Reclassifications<i> </i></p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 8.3pt 0 0 43.45pt; text-align: justify">Certain prior period amounts have been reclassified to conform to current presentation. </p> <p style="font: 9.5pt Times New Roman, Times, Serif; margin: 8.3pt 0 0 43.45pt; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zlXMbmPFVsOc" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0 0 0 22.5pt; text-align: justify; text-indent: 0in"><span style="font-size: 9.5pt">i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span> <span style="font-size: 9.5pt">Substantial doubt about the Company’s Ability to Continue as a Going Concern</span></p> <p style="font: 9.5pt/110% Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company’s negative cash flow from operations raises substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font: 9.5pt/111% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2019Q4	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	75000	usd
CY2019Q4	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	67500	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	40000000	shares
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0035
CY2022	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	500000	usd
CY2022	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-11-23
CY2021Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0165
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14398892	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4515	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	164265	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-4515	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-164265	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	14331600	usd
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	14353100	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	14331600	usd
CY2020Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	14353100	usd
CY2022	us-gaap	Revenues Revenues	2033712	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1502046	usd
CY2022	us-gaap	Gross Profit GrossProfit	531666	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	696343	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-164677	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	186177	usd
CY2022	cmgo	Net Income Loss Segment Reporting NetIncomeLossSegmentReporting	21500	usd
CY2021	us-gaap	Revenues Revenues	1618874	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1214281	usd
CY2021	us-gaap	Gross Profit GrossProfit	404593	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	708007	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-303414	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1092784	usd
CY2021	cmgo	Net Income Loss Segment Reporting NetIncomeLossSegmentReporting	789370	usd
CY2022	us-gaap	Related Party Transaction Rate RelatedPartyTransactionRate	0	pure
CY2021Q4	us-gaap	Loans Payable LoansPayable	15000	usd
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	40000000	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0155
	cmgo	Term Of Warrant TermOfWarrant	P5Y
CY2017Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0035
	cmgo	Term Of Warrant TermOfWarrant	P5Y

Files In Submission

Name	View Source	Status
cmgo-20221231_pre.xml	Edgar Link	unprocessable
0001017386-23-000162-index-headers.html	Edgar Link	pending
0001017386-23-000162-index.html	Edgar Link	pending
0001017386-23-000162.txt	Edgar Link	pending
0001017386-23-000162-xbrl.zip	Edgar Link	pending
cmgo-20221231.xsd	Edgar Link	pending
cmgo_2022dec31-10k.htm	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cmgo-20221231_cal.xml	Edgar Link	unprocessable
cmgo_2022dec31-10k_htm.xml	Edgar Link	completed
cmgo-20221231_def.xml	Edgar Link	unprocessable
cmgo-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMGO
CMG HOLDINGS GROUP, INC. Stock $cmgo

2023 Q1 Form 10-K Financial Statement

#000101738623000162 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMGO CMG HOLDINGS GROUP, INC. Stock $cmgo

2023 Q1 Form 10-K Financial Statement

#000101738623000162 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMGO
CMG HOLDINGS GROUP, INC. Stock $cmgo